Guerrero Ramiro 4
4 · MAIA Biotechnology, Inc. · Filed Dec 13, 2024
Insider Transaction Report
Form 4
Guerrero Ramiro
Director
Transactions
- Purchase
Common Stock
2024-12-13$1.87/sh+53,418$99,998→ 514,970 total - Purchase
Warrants
2024-12-13$2.08/sh+53,418$111,109→ 53,418 totalExercise: $2.08From: 2025-06-13Exp: 2030-06-13→ Common Stock (53,418 underlying)
Footnotes (2)
- [F1]The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on December 13, 2024.
- [F2]These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on December 13, 2024. The options are exercisable beginning on the six month anniversary of the issuance date and expire 5-years after the initial exercise date.